In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

And fourth, focus on changing the environment, not just people. We must shift the focus to the systems and structures that ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic obesity, according to a presenter. As Healio previously reported, ...

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...